Logo

Bridge Capital Provides $7M Line of Credit for Fluidigm

Apr 08, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bridge Capital Holdings and its subsidiary Bridge Bank National Association said after the close of the market on Thursday that they have provided Fluidigm with a $7 million line of credit.

The credit line was originally established in December 2010, when it was set at $4 million, according to a document filed with the US Securities and Exchange Commission in January.

The South San Francisco, Calif.-based company, which develops microfluidic systems for the life sciences and agricultural biotechnology industries, went public in February. Fluidigm CFO Vikram Jog said today that the financing will provide the company with greater flexibility to manage its working capital.

Filed under

PCR
Sequencing
Next-Generation Sequencing
Fluidigm
ABRF
Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.